These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
11/11/2015
7:30 AM ET
Press Release

Repligen to Present at the Stifel 2015 Healthcare Conference

11/11/2015

WALTHAM, Mass., Nov. 11, 2015 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced its upcoming presentation at the Stifel 2015 Healthcare Conference, being held next week at the L...

 Continue Reading
11/5/2015
7:30 AM ET
Earnings Release

Repligen Reports Third Quarter 2015 Financial Results

11/5/2015

- Product Sales Increase 31% to $19.8 Million -

- Conference Call and Webcast Today at 8:30 a.m. ET -

WALTHAM, Mass., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Repligen Corporation (N...

 Continue Reading
10/22/2015
6:19 PM ET
Press Release

CORRECTION -- Repligen to Report Third Quarter 2015 Financial Results

10/22/2015

WALTHAM, Mass., Oct. 22, 2015 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that it will report third quarter 2015 financial results on Thursday, November 5, 2015. The Compa...

 Continue Reading
10/22/2015
7:34 AM ET
Press Release

Repligen to Report Third Quarter 2015 Financial Results

10/22/2015

WALTHAM, Mass., Oct. 22, 2015 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that it will report third quarter 2015 financial results on Thursday, November 5, 2015. The Compa...

 Continue Reading
9/15/2015
7:30 AM ET
Press Release

Repligen Appoints Glenn P. Muir to Board of Directors

9/15/2015

WALTHAM, Mass., Sept. 15, 2015 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that life sciences industry veteran Glenn P. Muir has been elected to its Board of Directors and...

 Continue Reading
Displaying 1 to 5 (of 167 releases)
Copyright 2016, © SNL Financial LC  Terms of Use